Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Levoleucovorin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,410Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    After Cancer Drug Fails Pancreatic Cancer Trial, Lilly Plans to Continue Studies
    After Cancer Drug Fails Pancreatic Cancer Trial, Lilly Plans to Continue Studies

    17 Oct 2019

    // Mark Terry BIOSPACE

    https://www.biospace.com/article/lilly-s-pancreatic-drug-flunks-phase-iii-trial/?s=95

    Mark Terry BIOSPACE
    17 Oct 2019
    Share Share
    Mylan, Hospira both recall injected drugs after particulate discovered in vials
    Mylan, Hospira both recall injected drugs after particulate discovered in vials

    20 Mar 2019

    // Eric Palmer FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/mylan-and-hospira-recall-different-drugs-after-particulate-discovered-vials

    Eric Palmer FIERCE PHARMA
    20 Mar 2019
    Share Share
    Mylan Institutional Recalls Levoleucovorin Injection
    Mylan Institutional Recalls Levoleucovorin Injection

    19 Mar 2019

    // FDA

    https://www.fda.gov/Safety/Recalls/ucm633784.htm

    FDA
    19 Mar 2019
    Share Share
    Deals and M&As this week: Alnylam Pharmaceuticals, Novartis
    Deals and M&As this week: Alnylam Pharmaceuticals, Novartis

    25 Jan 2019

    // PHARMA TECH

    https://www.pharmaceutical-technology.com/news/deals-and-mas-this-week-alnylam-pharmaceuticals-novartis/

    PHARMA TECH
    25 Jan 2019
    Share Share
    Amneal Pharm’s Generic Levoleucovorin Receives Tentative Approval In US
    Amneal Pharm’s Generic Levoleucovorin Receives Tentative Approval In US

    07 Jul 2017

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207548

    FDA
    07 Jul 2017
    Share Share
    NICE Rejects Shire’s Pancreatic Cancer Drug
    NICE Rejects Shire’s Pancreatic Cancer Drug

    17 Nov 2016

    // Selina McKee PHARMATIMES

    http://www.pharmatimes.com/news/nice_rejects_shires_pancreatic_cancer_drug_1177060

    Selina McKee PHARMATIMES
    17 Nov 2016
    Share Share